Leading Radiology Forward

Strong Recovery in 2H 2020 2020 Third Quarter Highlights 2020 Fourth Quarter Highlights EBITDA ↑11.7% Up from 3Q 2019 EBITDA MARGIN ↑1.7% REVENUE ↑2.5% EBITDA ↑8.1% Up from 3Q 2019 Up from 4Q 2019 Up from 4Q 2019 EBITDA MARGIN ↑0.8% Up from 4Q 2019 . . Revenue and Adj. EBITDA increased 53.1% and 102.8%, respectively as compared to 2Q 2020 Revenue only decreased 0.3% as compared with 3Q 2019 Adjusted EBITDA increased 11.7% as compared with 3Q 2019 Adjusted EBITDA margin increased 1.7% as compared with 3Q 2019 • Revenue was the highest fourth quarter revenue and adjusted EBITDA in RadNet history Revenue increased 2.5% as compared with 4Q 2019 • Adjusted EBITDA increased 8.1% as compared with 4Q 2019 Adjusted EBITDA margin increased 0.8% as compared with 4Q 2019 • DSOs at December 31, 2020 was 36.2 days, the lowest in Company history Quarter over quarter improvement is evident and expected to continue into 2021 - publicly disclosed 2021 guidance ranges are demonstrative of this recovery with both 2021E Revenue and Adj. EBITDA in line with annualized 2H 2020 performance RadNet. Leading Radiology Forward 4

View entire presentation